On April 30, the U.S. Food and Drug Administration (FDA) approved Raplixa (fibrin sealant [human]), the first spray-dried fibrin sealant approved by the agency. Raplixa is used to help control intraoperative bleeding. Read more.
FDA approves Raplixa to help control bleeding during surgery
*Online Bonus Content: This has not been peer reviewed. The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal.